Clinical Trial Update: TRIGLYTZA® VERSUS METFORMIN IN OBESE ADULT TYPE 2 DIABETES (T2DM) PATIENTS OVER 24 WEEKS OF TREATMENT [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update describes a study comparing TRIGLYTZA with Metformin in obese adults with type 2 diabetes over 24 weeks; the trial status is not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• TRIGLYTZA
• metformin (metformin)

Snippet

Sponsor: Myopharm Limited | Conditions: Type 2 Diabetes (T2DM) | Phase 2 | Status: NOT_YET_RECRUITING